JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM Journal
Overview
publication venue for
- Norfolk QOL-DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy. 19:104-114. 2014
- Topiramate as a disease modifying therapy for cryptogenic sensory peripheral neuropathy: Design and analysis plan 2018
- DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF HEPATOCYTE GROWTH FACTOR GENE THERAPY IN PAINFUL DIABETIC NEUROPATHY 2015
- DISTORTED LANGERHANS CELLS IN DIABETIC PERIPHERAL NEUROPATHY 2011
- INTRAEPIDERMAL NERVE FIBER DENSITY (IENFD) PERFORMANCE IN A MULTICENTER DIABETIC NEUROPATHY CLINICAL TRIAL 2011
- INTRAEPIDERMAL NERVE FIBER DENSITY RELATIONSHIP TO NEUROLOGIC AND QUALITY OF LIFE OUTCOMES IN PATIENTS WITH V30M TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY 2011
- SAFETY AND EFFICACY OF MCC-257 IN DIABETIC PERIPHERAL NEUROPATHY: RESULTS OF A MULTICENTER RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL AND OPEN-LABEL EXTENSION 2011
- VALIDATION OF NORFOLK QOL-DN AS A MEASURE OF QOL IN PATIENTS WITH TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY 2011
- THE NEUROTOXICITY-INDUCED NEUROBLASTOMA APOPTOSIS (NINA) ASSAY PREDICTS A ROLE FOR SERUM LIPOPROTEINS IN THE DEVELOPMENT OF DIABETIC NEUROPATHY 2009
- Topiramate improves intraepidermal nerve fiber morphology and quantitative neuropathy measures in diabetic neuropathy patients 2005
- Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab) 2014
Identity
International Standard Serial Number (ISSN)
- 1085-9489
Electronic International Standard Serial Number (EISSN)
- 1529-8027